SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-057204
Filing Date
2019-10-29
Accepted
2019-10-29 13:31:32
Documents
4
Period of Report
2019-10-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-20651_28k.htm 8-K 36464
2 EX-10.1 a19-20651_2ex10d1.htm EX-10.1 89995
3 EX-99.1 a19-20651_2ex99d1.htm EX-99.1 13441
4 GRAPHIC g206512mmi001.jpg GRAPHIC 3846
  Complete submission text file 0001104659-19-057204.txt   146584
Mailing Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087
Business Address 170 N RADNOR CHESTER RD SUITE 250 RADNOR PA 19087 484-801-4670
MARINUS PHARMACEUTICALS INC (Filer) CIK: 0001267813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36576 | Film No.: 191175766
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences